Tag Archives: Chantix

Pharm Exec's Brands of Yesteryear: Where Are They Now?

Pharm Exec’s Brand of the Year selections from the last few years are still alive and kicking, although some have aged more gracefully than others. The US drug pricing wars may be coming, but these products already made their mint. We checked back in with them to see how things are going, and to look […]
Posted in Pharm Exec Magazine, R&D, Strategy | Also tagged , , , , , | Leave a comment

Pfizer Responds to Adverse Events Report

A report released last week by the The Institute for Safe Medication Practices (and covered yesterday on PharmExec.com), listed Pfizer’s smoking cessation drug Chantix as the number one most reported drug for adverse reactions in the first quarter of 2008. The report states that FDA received 1,001 reports of serious side effects for varenicline (the […]
Posted in Safety | Also tagged , , , , , | 2 Comments
  • Categories

  • Meta